Histologix

Histologix is a specialist Contract Research Organization (CRO) based in the United Kingdom that provides comprehensive histology, immunohistochemistry (IHC), and digital pathology services. The company supports the global pharmaceutical and biotechnology sectors by offering GLP and GCP-compliant tissue-based analysis for pre-clinical and clinical drug development. Key service offerings include tissue cross-reactivity (TCR) studies, in situ hybridization (ISH), and sophisticated multiplex immunofluorescence. In August 2022, Histologix was acquired by Source BioScience, a move that integrated its specialized pathology expertise into a broader suite of laboratory and clinical services. The company is recognized for its technical excellence in supporting regulatory submissions for novel biotherapeutics.